Management of Left Portal Hypertension

Clinical Manifestations

Splenomegalia and hypersplenism with consequent reduction of blood cells are common manifestations of left portal hypertension, often accompanied by varices and gastropathy 1
Collateral portosystemic vessels can be detected through abdominal imaging, which is crucial for diagnosis and treatment planning 1
Variceal bleeding is a severe complication of left portal hypertension, with varices being a common finding in affected patients 1

Abdominal ultrasound with Doppler is essential for evaluating the patency of the splenic vein and the presence of collaterals, providing valuable information for diagnosis and treatment 1
Endoscopy is crucial for identifying and classifying gastric varices, allowing for timely intervention and management 2

Pharmacological therapy with vasoactive agents, such as octreotide, should be initiated immediately in cases of suspected variceal bleeding, as it improves hemostasis and reduces the risk of rebleeding 3
Endoscopic variceal ligation (EBL) is the first-line treatment for esophageal variceal bleeding, with a high success rate and low complication rate 2
Combination therapy with vasoactive agents and endoscopic treatment significantly improves hemostasis at 5 days, reducing the risk of rebleeding and improving patient outcomes 3
Antibiotic prophylaxis in patients with acute gastrointestinal bleeding reduces mortality, bacterial infections, and rebleeding, and should be considered as part of the treatment protocol 3

Regular endoscopic monitoring is necessary to evaluate the response to treatment and identify early signs of variceal recurrence, allowing for timely intervention and prevention of complications 2
Imaging studies, such as Doppler ultrasound or CT, should be used to evaluate the patency of the splenic vein after recanalization, ensuring the effectiveness of the treatment and monitoring for potential complications 2

The American College of Radiology recommends the use of TIPS (transjugular intrahepatic portosystemic shunt) primarily for generalized portal hypertension secondary to cirrhosis, rather than left portal hypertension 4